Navigation Links
Genaera Corporation Elects Paul K. Wotton to Board of Directors
Date:6/30/2008

Wotton. "I look forward to working diligently with Jack and his team to competitively position the Company as a player in the growing metabolic disease market."

About Genaera

Genaera Corporation is focused on advancing the science and treatment of metabolic diseases. The Company has significant market opportunities with a first-in-class molecule, trodusquemine (MSI-1436), that has the potential to redefine the treatment paradigm for obesity and type 2 diabetes and is presently in a phase 1 trial in obesity. In addition, Genaera has a value-driven, fully out-licensed partnership with MedImmune, Inc. for a second core program that is presently undergoing phase 2 clinical testing in asthma. Genaera is committed to directing resources to its core program and the aggressive clinical development of its key assets to build stockholder value. For further information, please see our website at http://www.genaera.com.

This announcement contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks and uncertainties, known and unknown. Forward-looking statements reflect management's current views and are based on certain expectations and assumptions. Such statements include, among others, statements regarding the preliminary results, clinical development plans and prospects for Genaera's programs including trodusquemine (MSI-1436) and the IL-9 antibody program. You may identify some of these forward-looking statements by the use of words in the statements such as "anticipate," "believe," "continue," "develop," "expect," "plan" and "potential" or other words of similar meaning. Genaera's actual results and performance could differ materially from those currently anticipated and expressed in these and other forward-looking statements as a result of a number of risk factors, including, but not limited to: Genaera's history of operating
'/>"/>

SOURCE Genaera Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Genaera Corporation to Present at BIO Business Forum
2. Genaera Corporation Announces First Quarter Financial Results
3. Genaera Corporation Announces 2007 Financial Results
4. Genaera Corporation to Participate in Diabetes and Obesity Panel at RBC Capital Markets Healthcare Conference
5. Genaera Corporation Announces Third Quarter Financial Results
6. Genaera to Present at Biotech 2007 and BIO InvestorForum
7. Genaera Elects New Board Member and Announces Executive Appointments
8. BioTime, Inc. and Embryome Sciences, Inc. Sign Agreement With International Stem Cell Corporation to Provide Unique Human Stem Cell Lines for Research Use
9. U.S. Commerce Secretary Gutierrez Cuts Ribbon on MaxWell Biocorporations New Pharmaceutical Development Center and Quality Control Laboratory in Ukraine
10. FierceBiotech Names NanoBio Corporation as One of the Fierce 15 Biotech Companies of 2008
11. Allegiance Equity Corporation announces collaboration with Canadian Dairy Commission and Guelph Food Technologies Corporation for Alzheimers and Dementia formulation GG-XT
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... Biomarkers and Clinigene International are set to unveil their ... 2013 AAPS/ National Biotechnology Conference May 20-22 ... Marina , San Diego, CA. ... company representatives at their collaborative seminar, "Biosimilarity, Immunogenicity and ... 1-2 p.m. in the conference,s Spinnaker Room. ...
(Date:5/20/2013)... HILL, N.C. , May 20, 2013 /PRNewswire/ ... company focused on developing differentiated antibiotics to meet ... infections, today announced that it presented data at ... in Philadelphia demonstrating the ... levofloxacin in Cempra,s prior Phase 2 clinical trial ...
(Date:5/20/2013)... Interventional cardiologist Tony Farah, MD, and his ... Cardiovascular Institute have helped pioneer many breakthroughs in ... over the past three decades, from new disease-fighting medications ... artery stent implantation. , Today, AGH officials announced that ... in the study of a novel, first-of-its kind investigational ...
(Date:5/20/2013)... 2013 On 25-28 July, 2013, UPCP ... Paris - the beautiful city of lights. , According ... is revolutionizing the medical world. Understanding and integrating genetic ... hallmark of this transformation. Much of the present medical ... epidemiologic studies of large cohorts that do not take ...
Breaking Biology Technology:Pacific Biomarkers and Clinigene International To Announce Laboratory Solutions for Developers of Biosimilars at 2013 AAPS/ National Biotechnology Conference 2Cempra Presents Post-Phase 2 Analysis of Solithromycin's Efficacy and Safety Results from Patients with Community Acquired Bacterial Pneumonia (CABP) 2Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 2Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 3Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 4The International Congress on Personalized Medicine - Up Close and Personalized 2013 in Paris 2
... , May 18, 2010 , , ... - With Photo , , , ... safety device is now cleared by FDA for Home/Self use and is,consequently available to all ... dislodgement,during hemodialysis and its use has already improved in-clinic patient,safety. Optimizing safety conditions for home ...
... ... highly specialized metal tubing and innovative suppliers with ultra-fine finishing capabilities , ... (PRWEB) -- The increased miniaturization ... off in many ways. One of the integral items that have helped to ...
... , ... METTLER TOLEDO announced a collaboration to combine their existing technologies to offer flow reactor ... production. , ... (PRWEB) -- ThalesNano and METTLER TOLEDO announced a partnership to offer flow reactor technology ...
Cached Biology Technology:Redsense Medical Receives FDA Clearance for the Redsense Safety Device for Home/Self use During Home Hemodialysis 2Ultra-Fine Metal Tubing Smoothes the Way for Miniaturized Medical Devices 2Ultra-Fine Metal Tubing Smoothes the Way for Miniaturized Medical Devices 3METTLER TOLEDO and ThalesNano Bring Real-time Reaction Monitoring to Flow Synthesis 2METTLER TOLEDO and ThalesNano Bring Real-time Reaction Monitoring to Flow Synthesis 3METTLER TOLEDO and ThalesNano Bring Real-time Reaction Monitoring to Flow Synthesis 4
(Date:5/19/2013)... study reports that white men and women of European ... valgus) and lesser toe deformities, including hammer or claw ... estimate the heritability of foot disorders in humansappear in ... by Wiley on behalf of the American College of ... many as 60% of older adults have foot disorders ...
(Date:5/18/2013)... today at Digestive Disease Week (DDW) explores new discoveries ... of coffee on autoimmune disease and palliative care for ... been associated with reduced risk of fibrosis, a new ... java each month also correlate with lower risk for ... Clinic, Rochester, MN, linked coffee consumption with reduced risk ...
(Date:5/17/2013)... South, but the night belongs to the amphibians. In ... humidity and the sounds of wildlife. , The Southeast, ... salamanders, is the center of amphibian biodiversity in our nation. ... their symphonic choruses, the scientists of the U.S. Geological Survey,s ... , Amphibians, which rely on water for part ...
Breaking Biology News(10 mins):Blame your parents for bunion woes 2Coffee consumption associated with reduced risk of autoimmune liver disease 2Front-row seats to climate change 2Front-row seats to climate change 3Front-row seats to climate change 4
... soon be able to wear contact lenses that continuously ... changing colours replacing the need to routinely draw ... by Chemical and Biochemical Engineering professor Jin Zhang at ... embedded into the hydrogel lenses. These engineered nanoparticles ...
... the deoxycytidine kinase (dCK) enzyme have defects in their ... T and B lymphocytes, the major players involved in ... UCLA,s Jonsson Comprehensive Cancer Center. The finding could ... body attacks itself, and possibly certain cancers of the ...
... common minerals in biology, including those in bones and shells, have ... making them behave as one giant crystal, even though they do ... grains of salt were spilled on a rug, yet instead of ... rotation. In a new study in the Journal ...
Cached Biology News:Enzyme necessary for development of healthy immune system 2Enzyme necessary for development of healthy immune system 3Dental delight: Tooth of sea urchin shows formation of biominerals 2Dental delight: Tooth of sea urchin shows formation of biominerals 3
Rat Normal Multiple Tissue Array 1 slide...
... offers major advantages over other RNA precipitation methods ... or carbohydrates. It is the method of choice ... from RNA preparations. Note, LiCl precipitation may not ... If the RNA is to be used for ...
...
...
Biology Products: